Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12614000002684Phase 2Terminated
Phase 2, open-label trial of dexpanthenol in diaper dermatitis (2 arms), sponsored by HoneyLab. Primary endpoint: Nappy rash severity score (NRSS) of 1 or greater. Started Feb 2014; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12614000002684.